Contrary to previous findings, placing a stent in a valve clogged with lipid-rich plaque does not pose a greater risk of adverse outcomes compared to performing the procedure on non-lipid-rich plaque. 

Several factors—from medical to mental—can inhibit sexual function in men after a major cardiac event.  

An observational, prospective study found that there was a 98.8 percent technical success rate with the investigational Amplatzer Amulet LAA Occluder in patients with non-valvular atrial fibrillation.

More than 95 percent of implantations with the Watchman device for left atrial appendage occlusion in patients with non-valvular atrial fibrillation were successful, according to an analysis of procedural data.

Although St. Jude Medical recalled certain implantable heart defibrillators in 2015, the company acknowledged that it had continued to ship the old devices for up to 17 months, the Minneapolis Star Tribune reports.

A prospective, randomized trial in Japan found that follow-up coronary angiography following successful PCI had no clinical benefits and was associated with increased early revascularization rates.

Two new trials on eluting heart stents designed to treat unprotected left main coronary artery disease were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference, and they have left cardiologists stumped over their conflicting findings. 

Patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) with the Sapien first generation device had positive hemodynamics up to five years following implant, according to an analysis of a randomized trial.